Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NOTV
|
Jeffrey Arthur Krupp
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 2,036 Reduced 6.55% |
$9,121
$4.48 p/Share
|
Jan 31
2025 |
|
NOTV
|
John E Sagartz
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 2,118 Reduced 0.3% |
$9,488
$4.48 p/Share
|
Jan 31
2025 |
|
ACRE
|
Jeffrey Michael Gonzales
CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 4,020 Reduced 7.34% |
$22,833
$5.68 p/Share
|
Jan 31
2025 |
|
NOTV
|
Beth Taylor
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,054 Reduced 1.79% |
$9,160
$4.46 p/Share
|
Jan 31
2025 |
|
ACRE
|
Bryan Patrick Donohoe
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 23,465 Reduced 9.68% |
$133,281
$5.68 p/Share
|
Jan 31
2025 |
|
PH
|
Mark T Czaja
VP & Chief Tech. & Innov. Off. |
SELL
Open market or private sale
|
Direct | 375 Reduced 10.38% |
$266,947
$711.86 p/Share
|
Jan 31
2025 |
|
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$23,020
$11.51 p/Share
|
Jan 31
2025 |
|
SANM
|
Alan Mc Williams Reid
EVP, Global Human Resources |
SELL
Open market or private sale
|
Direct | 3,451 Reduced 8.52% |
$290,919
$84.3 p/Share
|
Jan 31
2025 |
|
SANM
|
Charlie Mason
EVP & Global Sales |
SELL
Open market or private sale
|
Direct | 12,717 Reduced 28.76% |
$1,067,083
$83.91 p/Share
|
Jan 31
2025 |
|
FRAF
|
Craig W Best
President |
BUY
Open market or private purchase
|
Direct | 7,350 Added 45.37% |
$249,312
$33.92 p/Share
|
Jan 31
2025 |
|
BUSE
|
Stephen V King
Director |
BUY
Open market or private purchase
|
Indirect | 16,427 Added 0.0% |
$402,954
$24.53 p/Share
|
Jan 31
2025 |
|
BUSE
|
Stanley J Bradshaw
Director |
BUY
Open market or private purchase
|
Direct | 5,500 Added 1.26% |
$133,265
$24.23 p/Share
|
Jan 31
2025 |
|
PNC
|
William S Demchak
CEO |
SELL
Open market or private sale
|
Direct | 1,242 Reduced 0.24% |
$251,020
$202.11 p/Share
|
Jan 31
2025 |
|
HNVR
|
Robert Golden
Director |
SELL
Open market or private sale
|
Indirect | 2,272 Reduced 0.0% |
$60,616
$26.68 p/Share
|
Jan 31
2025 |
|
MTRN
|
Shelly Marie Chadwick
Vice President, Finance & CFO |
SELL
Open market or private sale
|
Direct | 805 Reduced 5.21% |
$81,498
$101.24 p/Share
|
Jan 31
2025 |
|
URGN
|
Jason Drew Smith
General Counsel |
SELL
Open market or private sale
|
Direct | 7,379 Reduced 18.5% |
$82,202
$11.14 p/Share
|
Jan 31
2025 |
|
BYFC
|
Wayne Kent A. Bradshaw |
SELL
Open market or private sale
|
Direct | 445 Reduced 1.16% |
$3,471
$7.8 p/Share
|
Jan 31
2025 |
|
URGN
|
Mark Schoenberg
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 4,551 Reduced 2.97% |
$50,698
$11.14 p/Share
|
Jan 31
2025 |
|
ORI
|
Jeffrey Lange
SVPUnderwriting & Distribution |
SELL
Open market or private sale
|
Direct | 1,098 Reduced 3.07% |
$40,142
$36.56 p/Share
|
Jan 31
2025 |
|
MODV
|
Ai Catalyst Fund, LP |
BUY
Open market or private purchase
|
Direct | 187,500 Added 8.8% |
$755,625
$4.03 p/Share
|
Jan 31
2025 |
|
IMNM
|
Clay B Siegall
President and CEO |
BUY
Open market or private purchase
|
Direct | 150,000 Added 18.3% |
$1,162,500
$7.75 p/Share
|
Jan 31
2025 |
|
BBNX
|
Mike Mensinger
Chief Product Officer |
BUY
Open market or private purchase
|
Direct | 33,350 Added 36.11% |
$566,950
$17.0 p/Share
|
Jan 31
2025 |
|
BBNX
|
Mike Mensinger
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 13 Reduced 0.05% |
$221
$17.0 p/Share
|
Jan 31
2025 |
|
CLS
|
Yann L Etienvre
Chief Operations Officer |
SELL
Open market or private sale
|
Direct | 9,181 Reduced 100.0% |
$1,170,944
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Mandeep Chawla
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,483 Reduced 100.0% |
$1,209,461
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Todd C Cooper
President |
SELL
Open market or private sale
|
Direct | 9,538 Reduced 5.16% |
$1,216,476
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Alok K. Agrawal
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 1,763 Reduced 16.05% |
$224,853
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Robert Mionis
President & CEO |
SELL
Open market or private sale
|
Direct | 52,588 Reduced 9.0% |
$6,707,073
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Leila Wong
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 3,161 Reduced 18.54% |
$403,153
$127.54 p/Share
|
Jan 31
2025 |
|
CLS
|
Jason Phillips
President |
SELL
Open market or private sale
|
Direct | 10,851 Reduced 100.0% |
$1,383,936
$127.54 p/Share
|
Jan 31
2025 |
|
NRIX
|
Christine Ring
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 5,760 Reduced 15.04% |
$116,409
$20.21 p/Share
|
Jan 31
2025 |
|
KALV
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect | 11,754 Added 0.0% |
$104,493
$8.89 p/Share
|
Jan 31
2025 |
|
IONS
|
C Frank Bennett
EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 1,327 Reduced 1.4% |
$43,074
$32.46 p/Share
|
Jan 31
2025 |
|
IONS
|
Richard S Geary
EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct | 1,406 Reduced 1.4% |
$45,554
$32.4 p/Share
|
Jan 31
2025 |
|
IONS
|
Elizabeth L Hougen
EVP, Finance & CFO |
SELL
Open market or private sale
|
Direct | 1,523 Reduced 1.36% |
$49,406
$32.44 p/Share
|
Jan 31
2025 |
|
IONS
|
Brett P Monia
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 13,242 Reduced 5.69% |
$429,702
$32.45 p/Share
|
Jan 31
2025 |
|
IONS
|
Patrick R. O'Neil
EVP CLO & General Counsel |
SELL
Open market or private sale
|
Direct | 1,406 Reduced 2.16% |
$45,680
$32.49 p/Share
|
Jan 31
2025 |
|
IONS
|
Eugene Schneider
EVP, Chf Clinical Develop Ofcr |
SELL
Open market or private sale
|
Direct | 1,484 Reduced 2.37% |
$47,784
$32.2 p/Share
|
Jan 31
2025 |
|
IONS
|
Eric Swayze
EVP Research |
SELL
Open market or private sale
|
Direct | 1,367 Reduced 2.77% |
$44,167
$32.31 p/Share
|
Jan 31
2025 |
|
SIRI
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 840,000 Added 0.0% |
$19,840,800
$23.62 p/Share
|
Jan 31
2025 |
|
SYM
|
Michael David Dunn
Officer |
SELL
Open market or private sale
|
Indirect | 2,450 Reduced 0.0% |
$73,500
$30.0 p/Share
|
Jan 31
2025 |
|
NSC
|
Gilbert H Lamphere
Director |
BUY
Open market or private purchase
|
Direct | 607 Added 19.62% |
$157,735
$259.86 p/Share
|
Jan 31
2025 |
|
SNAP
|
Michael J. O'Sullivan
General Counsel |
SELL
Open market or private sale
|
Indirect | 18,000 Reduced 0.0% |
$206,820
$11.49 p/Share
|
Jan 31
2025 |
|
SPSC
|
Jamie Thingelstad
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 68 Reduced 0.24% |
$12,565
$184.78 p/Share
|
Jan 31
2025 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 12,975 Reduced 0.0% |
$9,031,508
$696.07 p/Share
|
Jan 31
2025 |
|
SPSC
|
Dan Juckniess
EVP, Chief Sales Officer |
SELL
Open market or private sale
|
Direct | 2,395 Reduced 10.61% |
$443,625
$185.23 p/Share
|
Jan 31
2025 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 30,908 Reduced 0.0% |
$21,511,040
$695.97 p/Share
|
Jan 31
2025 |
|
INSW
|
William F. Nugent
Senior Vice President |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 2.01% |
$39,100
$39.1 p/Share
|
Jan 31
2025 |
|
TEAM
|
Gene Liu
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 779 Reduced 1.46% |
$249,287
$320.01 p/Share
|
Jan 31
2025 |
|
TEAM
|
Rajeev Bashyam Rajan
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 1.84% |
$1,120,035
$320.01 p/Share
|
Jan 31
2025 |